Welcome to our dedicated page for Nutex Health news (Ticker: NUTX), a resource for investors and traders seeking the latest updates and insights on Nutex Health stock.
Nutex Health Inc (NASDAQ: NUTX), a physician-led healthcare innovator, operates a unique dual-division model combining micro-hospitals with population health management. This page provides real-time access to official company announcements, financial disclosures, and strategic developments.
Investors and industry observers will find a centralized resource for earnings reports, partnership announcements, and updates on the company’s technology-driven care models. Track NUTX’s progress in expanding its network of concierge-style emergency centers and risk-bearing provider networks.
All content is sourced directly from verified corporate communications, ensuring accuracy for those analyzing healthcare sector trends or monitoring the company’s integration of cloud-based data platforms with clinical operations. Regular updates reflect NUTX’s commitments to operational transparency and community-focused care delivery.
Bookmark this page for efficient tracking of Nutex Health’s milestones in redefining emergency medicine and value-based care through its specialty hospitals and population health initiatives.
Nutex Health (NASDAQ: NUTX) reported strong financial results for FY2024, with total revenue reaching $479.9 million, up 93.8% from $247.6 million in 2023. The company achieved a significant turnaround with net income of $52.2 million compared to a net loss of $45.8 million in 2023, resulting in diluted EPS of $9.71.
Key highlights include EBITDA of $98.4 million and Adjusted EBITDA of $123.7 million, representing a 1,045.4% increase from 2023. The Hospital Division recorded 168,388 total visits, up 16.9% year-over-year. The company's arbitration efforts through the Independent Dispute Resolution process contributed significantly, resulting in approximately $169.7 million more in revenue compared to 2023.
As of December 31, 2024, Nutex Health maintained a strong balance sheet with total assets of $655.3 million, including $43.6 million in cash and cash equivalents, and long-term debt of $22.5 million. The company operates 24 micro hospitals and hospital outpatient departments across 11 states.
Nutex Health (NASDAQ: NUTX) has announced the rescheduling of its fourth quarter and full year 2024 financial results release and conference call. The company has moved the earnings release from March 27 to March 31, 2025 (after market close), with the conference call now scheduled for April 1, 2025 at 10:30 a.m. ET.
The company stated it is utilizing the full time allowed by regulations to complete its year-end reporting process. Investors can access the conference call through the dial-in numbers 1-877-407-9208 or 1-201-493-6784, with a recording to be made available on the company's website for those unable to attend live.
Nutex Health (NASDAQ: NUTX), a physician-led healthcare system operating 24 micro-hospitals across 11 states, has announced its participation in the EDPMA Solutions Summit 2025. CEO Dr. Tom Vo will deliver a presentation titled 'The Evolution of Micro Hospitals and How it Impacts Future Healthcare' on Tuesday, April 1, 2025, from 11:50 AM to 12:30 PM MT at The Broadmoor in Colorado Springs.
The presentation will take place in Broadmoor Hall DE, where management will also engage with industry leaders and healthcare disruptors. The Solutions Summit, focusing on emergency medicine business, will address key topics including:
- The No Surprises Act
- Reimbursement and Regulatory Policy
- Independent Dispute Resolution
- Revenue Cycle Management
Nutex Health (NASDAQ: NUTX), a physician-led healthcare system with 24 micro hospitals across 11 states, has announced its upcoming financial results release schedule. The company will disclose its Q4 and full-year 2024 financial results after market close on March 27th, 2025.
A conference call to discuss these results is scheduled for March 28th, 2025, at 10:30 am ET. Participants can join via phone (1-877-407-9208 or 1-201-493-6784) or through a webcast link. Those unable to attend can access the recording on the company's website.
Nutex Health (NASDAQ: NUTX) provided an update on its No Surprises Act (NSA) arbitration strategy implemented in July 2024. The company, which operates 24 micro-hospitals across 11 states, has achieved significant success with its Independent Dispute Resolution (IDR) process, submitting 60-70% of billable visits to arbitration monthly and maintaining an 80% success rate in Q4 2024.
The company partnered with a third-party vendor to recover underpaid out-of-network claims through arbitration. While the process involves substantial upfront costs and administrative delays, Nutex is beginning to realize the cash impact of these efforts. However, the company cautions that future success rates and claim recoveries are not guaranteed, citing potential regulatory changes and evolving arbitration practices as risk factors.
Nutex Health (NASDAQ: NUTX) has announced multiple community-driven awards and recognitions for its hospitals in Q4 2024, demonstrating excellence in healthcare delivery across its network of 24 micro-hospitals in 11 states.
Key achievements include: Fort Smith ER & Hospital winning Gold for 'Best Place to Work' and Silver for 'Best Hospital/Customer Service'; Oklahoma ER & Hospital being named 'Top Workplace 2024' for the third consecutive year; and Covington Trace ER & Hospital receiving the 'Service with a Smile' award and placing 2nd in the Heroes Who Cook competition.
Alexandria Emergency Hospital secured multiple honors at the 2024 Alexandria Community's Choice Awards, including 'Best Hospital Emergency Room' and 'Best Boss.' Additionally, Nutex Health was recognized on The Silicon Review magazine's '30 Innovative Companies to Watch 2024' list.
Nutex Health (NASDAQ: NUTX) announced the opening of Starkey Ranch ER & Hospital in Odessa, Florida on December 30, 2024, marking its fourth hospital opening in 2024. The 31,000-square-foot facility represents the company's first hospital in Florida and features 8 Emergency Room beds, 8 inpatient beds, one operating room, in-house laboratory services, pharmacy, and comprehensive imaging capabilities.
The facility joins Nutex Health's portfolio of 24 micro-hospitals across 11 states. This opening follows the launch of facilities in Green Bay and Milwaukee, Wisconsin, and Post Falls, Idaho earlier in 2024. The new hospital provides 24/7/365 concierge-level care, emphasizing short wait times and personalized attention from emergency-trained staff.
Nutex Health (NASDAQ: NUTX), a physician-led healthcare system operating 24 micro-hospitals across 11 states, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference, the industry's largest healthcare investment symposium.
The company's presentation is scheduled for Thursday, January 16, 2025, from 10:30 AM to 11:10 AM PST at the Elizabethan B Conference Room, Westin St. Francis Hotel in San Francisco. The conference runs from January 13th to 16th, 2025.
Company management will be available for one-on-one meetings with qualified registered investor community members during the conference.
Nutex Health (NASDAQ: NUTX) announced the opening of Milwaukee ER & Hospital, its third hospital opening in 2024 and second location in Wisconsin. The 20,000 square foot facility features 8 emergency room beds, 6 inpatient beds, one procedure room, an in-house pharmacy, laboratory services, and comprehensive imaging capabilities. The facility provides 24/7/365 concierge-level emergency care with board-certified physicians. This opening follows the launch of facilities in Green Bay, Wisconsin and Post Falls, Idaho, expanding Nutex's network to 23 micro hospitals and HOPDs across ten states.
Nutex Health reported strong financial results for Q3 2024, with total revenue reaching $78.8 million, up 26% from Q3 2023. For the first nine months of 2024, revenue grew 25% to $222.3 million compared to the same period in 2023. The Hospital Division saw significant growth with visits increasing 20% to 122,944 for the first nine months. Operating income improved to $16.4 million for the nine months, compared to a $5.6 million loss in 2023. The company generated $23.1 million in operating cash flow and reported $46.9 million in cash and cash equivalents. However, the company still recorded a net loss of $9.5 million for the nine-month period, though improved from $14.2 million loss in 2023.
